Zoetis Inc.

Zoetis Inc. is a leader in the discovery, development, manufacture, and commercialization of a broad range of animal health medicines and diagnostic products.

It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Zoetis's product lineup includes:

• Vaccines: Biological preparations designed to prevent diseases in respiratory, gastrointestinal, and reproductive systems, or to elicit a specific immune response.

• Anti-infectives: Products that prevent, kill, or inhibit the growth of bacteria, fungi, or protozoa.

• Parasiticides: Treatments that prevent or eliminate parasites like fleas, ticks, and worms.

• Pharmaceutical Products: This includes a range of therapeutic categories such as pain and sedation, antiemetic (anti-vomiting), reproductive, dermatology, and oncology products. Dermatology products, for instance, target conditions like itching associated with allergies and atopic dermatitis.

• Medicated Feed Additives: These deliver medication to livestock through feed.

Additionally, Zoetis offers diagnostic and monitoring tools, such as portable blood and urine analysis systems, point-of-care diagnostic instruments, rapid immunoassay tests, and reference laboratory kits.

The company also provides non-pharmaceutical products like nutritionals and precision animal health services.

Zoetis markets its products through direct sales forces, as well as veterinary and technical specialists to veterinarians, livestock producers, retail outlets, and through third-party veterinary distributors.

Founded in 1952, Zoetis is headquartered in Parsippany, New Jersey.